AFM
STIM icon

Anson Funds Management’s Neuronetics STIM Stock Holding History

Anson Funds Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-58,323
Closed -$260K – 424
2021
Q4 		$260K Buy
+58,323
New +$286K 0.03% 281

Other funds holding STIM

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Anson Funds Management's STIM Position: Q1 2022 in Review

Anson Funds Management sold out of Neuronetics (STIM) in Q1 2022, closing a stake of 58,323 shares — an estimated $260K sold.

Anson Funds Management first reported a position in STIM in Q4 2021 and held it in 1 quarter. The position peaked at $260K in Q4 2021. 83 funds tracked by Wall St. Rank hold STIM as of Q1 2022.

  • Anson Funds Management reported no remaining Neuronetics position as of Q1 2022 after selling out during the quarter.
  • Anson Funds Management sold 58,323 Neuronetics shares in Q1 2022, an estimated $260K.
  • Anson Funds Management first reported a position in Neuronetics in Q4 2021 and held it in 1 quarter.
  • Anson Funds Management's Neuronetics position peaked at $260K in Q4 2021.
  • 83 funds tracked by Wall St. Rank held Neuronetics as of Q1 2022.

Based on Anson Funds Management's 13F filing for Q1 2022, filed 12 May 2022.